Published in Curr Opin Immunol on October 01, 2010
The Role of B Cells in Kidney Allograft Dysfunction | NCT02294032
Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I). Vet Res (2011) 1.14
Essential role for B cells in transplantation tolerance. Curr Opin Immunol (2011) 0.89
HLA class I: an unexpected role in integrin β4 signaling in endothelial cells. Hum Immunol (2012) 0.78
A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes. Biomed Eng Online (2012) 0.78
Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation. Immunology (2013) 0.78
Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Sci Rep (2017) 0.75
Influence of immune responses in gene/stem cell therapies for muscular dystrophies. Biomed Res Int (2014) 0.75
B cells in transplantation. J Heart Lung Transplant (2016) 0.75
MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil. PLoS One (2017) 0.75
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med (1999) 7.41
B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 7.30
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol (2006) 5.22
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 5.13
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 4.84
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A (1996) 4.70
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol (2007) 4.46
Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science (2006) 3.84
Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity (2004) 3.75
Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol (2007) 3.63
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity (2007) 3.55
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest (2005) 3.48
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity (2007) 3.28
Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol (2004) 3.19
FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol (2007) 3.04
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity (2009) 2.98
Memory B-cell persistence is independent of persisting immunizing antigen. Nature (2000) 2.90
Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol (2009) 2.82
Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol (2007) 2.64
Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation (2010) 2.59
B-cell memory is short-lived in the absence of antigen. Nature (1988) 2.57
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity (2005) 2.57
Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol (2009) 2.49
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet (2009) 2.46
FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol (2010) 2.44
Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol (2009) 2.39
Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant (2009) 2.27
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant (2009) 2.22
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant (2004) 2.22
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med (2005) 2.01
Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol (1998) 1.96
Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant (2010) 1.96
Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood (1996) 1.92
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood (2007) 1.85
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation (2000) 1.85
Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation (2010) 1.83
Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68
Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation (2005) 1.64
BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci (2005) 1.64
Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood (2010) 1.63
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant (2004) 1.54
Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol (2004) 1.51
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest (2008) 1.50
Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2009) 1.49
The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation (2005) 1.44
Dendritic cells associated with plasmablast survival. Eur J Immunol (1999) 1.44
Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant (2004) 1.42
"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation (2008) 1.41
Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant (2006) 1.38
Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant (2008) 1.37
Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J Immunol (2000) 1.37
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol (2005) 1.36
The spectrum of antibody-mediated renal allograft injury: implications for treatment. Am J Transplant (2008) 1.33
Cross-reactions between streptococcal M proteins and human transplantation antigens. Science (1970) 1.33
B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med (2002) 1.32
A role for antigen in the maintenance of immunological memory. Nat Rev Immunol (2002) 1.30
Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation (2005) 1.29
B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells. Blood (2009) 1.26
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood (2008) 1.26
Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology (2009) 1.23
Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation (2007) 1.21
Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation (2009) 1.20
B cell inhibitory receptors and autoimmunity. Immunology (2003) 1.19
Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol (2000) 1.18
Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A (2005) 1.16
The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation (2004) 1.15
Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation (2010) 1.10
Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant (2005) 1.09
The effect of desensitization protocols on human splenic B-cell populations in vivo. Am J Transplant (2007) 1.08
Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol (2006) 1.08
BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant (2009) 1.06
Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol (2010) 1.05
Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc (2005) 1.04
ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant (2005) 1.04
Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci U S A (1983) 1.00
HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation (2007) 0.99
A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod (1991) 0.99
The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome. Transplant Proc (2003) 0.98
Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation (2002) 0.97
Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res (2010) 0.96
Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation (2004) 0.96
Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol (2003) 0.95
Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant (2005) 0.95
Effects of blood transfusions given after renal transplantation. Transplantation (2009) 0.94
B cells and plasma cells in coronaries of chronically rejected cardiac transplants. Transplantation (2010) 0.94
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet (1996) 0.93
Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation (1982) 0.93
Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant (2008) 0.93
Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies. Transplantation (2006) 0.90
Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum Immunol (2002) 0.88
Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation (2001) 0.88
The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection. Transplant Proc (2009) 0.87
Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation (1997) 0.86
Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology (1999) 0.98
The effect of sirolimus therapy on vaccine responses in transplant recipients. Am J Transplant (2007) 0.90
Rituximab in Churg-Strauss syndrome. Ann Rheum Dis (2006) 0.89
Baseline donor chronic renal injury confers the same transplant survival disadvantage for DCD and DBD kidneys. Am J Transplant (2015) 0.80
Pancreas graft salvage using pancreatico-duodenectomy with enteric drainage. Am J Transplant (2007) 0.78
Perioperative erythropoietin efficacy in renal transplantation. Transplant Proc (2007) 0.77
The role of intermediate filaments in early Xenopus development studied by antisense depletion of maternal mRNA. Dev Suppl (1992) 0.75
De-functioning polymorphism in the inhibitory receptor FcγRIIB does not impact upon kidney allograft survival. Clin Exp Immunol (2014) 0.75
Nosocomial transmission of Salmonella typhimurium in renal transplant recipients. J Hosp Infect (2010) 0.75